Register Early and Save up to $300 (See page ... - IBC Life Sciences

More documents

Recommendations

Info

The Most Extensive Biopharmaceutical Marketplace – Over 150 Vendors! About the Exhibition: The exhibition hall will provide you with many opportunities that you find most important when embarking on the venture through the hall. In addition to all of the products and services that will be featured, we have developed a fun and exciting environment that will allow you to explore, communicate, network and challenge your approaches. Exhibition Highlights: • An array of new products and services just released to the market • 90+ Scientific and Technical Posters with Dedicated Author Time • Tuesday “Opening Night” Cocktail Reception sponsored by • Wednesday Night Cocktail Reception sponsored by • Delegate Roundtable Luncheons • Poster Contest sponsored by • Face-to-Face Valuable Discussions with Over 1,500+ Attendees Who You Will Meet at BPI 2010 Exhibit Hall Hours Tuesday, September 21, 2010 5:30 pm – 7:00 pm Wednesday,September 22, 2010 9:45 am – 7:15 pm Thursday, September 23, 2010 9:45 am – 3:45 pm During the exhibit hall special events you will meet with Chief Scientific Officers, Vice Presidents, Directors, Managers and Plant Managers, Heads of Departments, Group/Team/Project Leaders, Senior Scientists, Engineers, Development and Technical/Application Specialists, Research Associates, Consultants and Analysts working in the following areas: • Process Development • Process Engineering • Cell Line Development and Engineering • Upstream Processing • Cell and Molecular Sciences • Protein Sciences • Media Development • Technical Operations • Bioprocess R&D • Drug Substance Development • Analytical Development • Regulatory Compliance/Affairs • Quality Assurance/Control • Purification • Supply Chain • Manufacturing • Strategic Planning • Business Development Exhibitor List (as of July 30, 2010) 3M Purification Inc Advanced Instruments Inc. Advanced Scientifics Inc. AdvantaPure / NewAge Industries Ajinomoto Althea Technologies , Inc Applied Biosystems Applikon Biotechnology Inc. Aragen Bioscience Inc. Arkema, Inc. Asahi Kasei Bioprocess ATMI Life Sciences ATR, Inc Avid Bioservices Inc. BAC B.V., The Affinity Experts BaroFold, Inc Baxter Bayer Technology Services BD Biosciences – Advanced Bioprocessing Bioengineering Inc. BioPharm Software Solutions BioProcess International TM Magazine Bioproduction Group Bio-Rad Laboratories BioReliance Corp BioScale, Inc BioSystem Development, LLC BioTechLogic Inc Boehringer Ingelheim GmbH BPSA Brightwell Technologies, Inc. Broadley-James Corporation Caliper Life Sciences Catalent Pharma Solutions Celeros Separations CEVEC Pharmaceuticals GmbH Charles River Charter Medical Ltd. Chisso Cisbio US, Inc CMC Biologics Cobra Biomanufacturing Colder Products Company Cook Pharmica LLC Corning Life Sciences Crucell Cygnus Technologies, Inc Cytovance Biologics, LLC DASGIP BioTools LLC DCI-Biolafitte Dionex Diosynth Biotechnology DSM Biologics Eden Biodesign EMD Chemicals Finesse Solutions LLC Flownamics Fluid Imaging Technologies, Inc FOGALE nanotech, Inc Forte Bio Friesland Campina Domo GE Healthcare GEA Westfalia Separator Genetix Goodwin Biotechnology, Inc Gore Pharmbio Products Gyros US Inc. Hamilton Company Health Protection Agency IDBS Invitrogen Irvine Scientific KBI Biopharma, Inc. Lancaster Laboratories Latham BioPharm Group LAUDA-Brinkmann LP Laureate Pharma LEWA Life Technologies Lonza Metanomics Health Millipore Mirus Bio Molecular Devices Natrix Separations New Brunswick Scientific Nova Biomedical NOVASEP Novozymes Biopharma Optek Pall Life Sciences PBS Biotech PendoTECH Pfenex PSA Carr Centritech Praxair Inc. PreSens Precision Sensing Prometic Biosciences Ltd. QOSINA Refine Technologies Rentschler Biotechnologie SAFC Biosciences Sandoz Sartorius Stedim North America Inc. SciLog, Inc. SEBRA Sheffield Smartflow Technologies Spectrum Laboratories Inc. The Automation Partnership Therapure Biopharma Thermo Scientific Tosoh Bioscience Transonic Systems Inc. Quattrflow Pumps/Triangle Process Equipment Value Plastics Inc. WuXi AppTec Xcellerex, Inc. Limited space still available To learn more about exhibiting at this year’s BioProcess International conference, please contact: Kristen Schott, Sales Executive (508) 614-1239 kschott@ibcusa.com Jennifer McElligott, Sales Executive (508) 614-1672 jmcelligott@ibcusa.com Visit www.IBCLifeSciences.com/BPI for up-to-date information on this event 14
Co-Located Conference Paid delegates for BioProcess International TM Conference & Exhibition may attend the sessions of this conference at no additional charge. IBC’s 10 th Annual Formulation Strategies for Protein Therapeutics A Case Study Forum on Improving the Pace and Quality of Formulation Development September 21-23, 2010 • Rhode Island Convention Center • Providence, RI For further information, and to access the speaker presentation abstracts, please visit: www.IBCLifeSciences.com/Formulation Tuesday, September 21, 2010 Pre-Conference Workshop: The Formulator of the Future: Using High Throughput Technologies, Informatics and Rational Design to Accelerate and Optimize Formulation Development 7:45 Registration and Networking Coffee 8:25 Chairperson’s Remarks David Volkin, Ph.D., Distinguished Professor, Pharmaceutical Chemistry, University of Kansas 8:30 Application of a High Throughput Screening Procedure with PEG-induced Precipitation to Compare Relative Protein Solubility during Formulation Development with IgG1 Monoclonal Antibodies Todd Gibson, Ph.D., Senior Research Scientist, Johnson & Johnson Pharmaceutical R&D, Inc. 9:00 Critical Analysis of Multiple Complex Datasets in Solving Challenges during Formulation Development and Protein Characterization Haripada Maity, Ph.D., Senior Scientific Manager, Formulation Development, ImClone Systems, A Wholly-Owned Subsidiary of Eli Lilly & Co. 9:30 CASE STUDY Characterization of Stability Characteristics of Drug Candidates in Discovery Research Sharon Gao, Ph.D., Principal Scientist, Analytical Biochemistry, Biogen Idec, Inc. 10:00 Networking Refreshment Break 10:30 CASE STUDY Incorporation of Fluorescence-Based Screening Technique to High-Throughput, Gated Workflow for Biologic Formulation Screening Pooja Arora, Ph.D., Research Investigator II, Bristol-Myers Squibb 11:00 Finding the Perfect Lead: Strategies to Select Proteins with Optimal Properties for Further Development Hubert Kettenberger, Ph.D., Senior Scientist, Protein Analytics, Roche Diagnostics GmbH, Germany 11:30 Panel Discussion with Workshop Speakers: Use and Limitations of HTS in Formulation Development 12:00 Workshop Ends; Lunch on Your Own Main Conference 1:10 Chairperson’s Remarks Haripada Maity, Ph.D., Senior Scientific Manager, Formulation Development, ImClone Systems, A Wholly-Owned Subsidiary of Eli Lilly & Co. Development of Formulation and Drug Product Design Space Keynote Presentation 1:15 Holistic QbD: The Integration of Formulation, Process Development and Process Validation Sherry Martin Moe, Ph.D., Director, Late Stage Pharmaceutical and Processing Development, Genentech, Inc. 2:00 CASE STUDY Lyophilization Process Validation based on Quality by Design Bingquan (Stuart) Wang, Ph.D., Senior Scientist, Pharmaceutics, Genzyme Corporation Keynote Presentation 2:30 Particles, Particles Everywhere: Causes, Consequences and Control of Aggregates and Subvisible Particles in Therapeutic Protein Formulations John F. Carpenter, Ph.D., Professor, Department of Pharmaceutical Sciences, University of Colorado 3:15 Networking Refreshment Break Comparability and Characterization Exercises during Formulation Development 3:45 CASE STUDY Comparability Assessments with Protein Therapeutic and Vaccine Dosage Forms: Challenges and Opportunities David Volkin, Ph.D., Distinguished Professor, Pharmaceutical Chemistry, University of Kansas 4:15 Characterization of Site Specific Degradation Pathways of Antibody-Maytansinoid Conjugates (AMC) Alex Lazar, Ph.D., Mass Spectrometry Group Leader, Analytical and Pharmaceutical Sciences Department, ImmunoGen, Inc. 4:45 CASE STUDY Evaluating the Impact of a Container Closure Change on the Stability of a Protein Therapeutic Angela W. Blake-Haskins, Ph.D., Senior Scientist II, Drug Product Sciences Department, Human Genome Sciences, Inc. 5:15 Session Ends 5:30 Opening Night Reception in the Exhibit and Poster Hall Sponsored by Wednesday, September 22, 2010 7:45 Networking Coffee 8:10 Chairperson’s Remarks Angela W. Blake-Haskins, Ph.D., Senior Scientist II, Drug Product Sciences Department, Human Genome Sciences, Inc. Keynote Presentation 8:15 Modeling Protein Degradation Processes and the Development of Rational Approaches to Stabilization Bernhardt Trout, Ph.D., Professor, Chemical Engineering, Massachusetts Institute of Technology Implementing Analytical Methods and Control Steps for Subvisible Particles Keynote Presentation 9:00 NIST Perspective on Standards and GMP Processes for Subvisible Particles in Protein Therapeutics Dean Ripple, Ph.D., Group Leader, Process Measurements Division, Process Sensing Group, National Institute of Standards and Technology 9:45 Networking Refreshment Break in Exhibit and Poster Hall Sponsored by 10:30 Does SEC-HPLC Tell the Whole Story Use of Orthogonal Methods to Detect Aggregates and Subvisible Particles Brian K. Meyer, Ph.D., Research Fellow, Merck Research Laboratories 11:00 Analysis of Subvisible Particles by Flow Microscopy Rajesh Krishnamurthy, Ph.D., Director, Analytical and Pharmaceutical Sciences, ImmunoGen, Inc. 11:30 CASE STUDY Investigation of Therapeutic Protein Particle Formation during Filling Operations Shona C. Patel, Ph.D., Senior Development Engineer, Merck Research Laboratories 12:00 Technology Workshop For further information on sponsoring a Technology Workshop, please contact Jennifer McElligott at jmcelligott@ibcusa.com or 508-614-1672 for additional information. 12:30 Networking Luncheon in BioProcess International Exhibit and Poster Hall 2:10 Chairperson’s Remarks Andrea Ji, Ph.D., Scientist, Genentech, Inc. Evaluation and Control of Biopharmaceutical Stability 2:15 CASE STUDY Mitigation of Oxidation in Therapeutic Proteins Andrea Ji, Ph.D., Scientist, Genentech, Inc. 2:45 CASE STUDY Formulation Development of Therapeutic Antibodies using High-throughput Fluorescence and Static Light Scattering Techniques: Role of Conformational and Colloidal Stability Sathish Hasige, Ph.D., Senior Scientist, Formulation Sciences, Process Biochemistry, MedImmune, Inc. 3:15 CASE STUDY The Impact of Prefilled Syringe Leachables on Protein Stability Xiaofeng Lu, Ph.D., Senior Scientist, Facet Biotech 3:45 Networking Refreshment Break in Exhibit and Poster Hall Sponsored by 4:30 Low Volume, High-Throughput Thermal Analysis of Proteins by Fluorescence Dye Binding using a RT-PCR Instrument Thomas Palm, Ph.D., Senior Research Investigator, Pharmaceutics, Bristol-Myers Squibb Company 5:00 CASE STUDY The Importance of Understanding the Physical State of Excipients in a Freeze-Dried Formulation: Implications for Overall Product Quality Juan Davagnino, Ph.D., Director, Biopharmaceutical Development, KBI Biopharma, Inc. 5:30 CASE STUDY Effects of Surface Tension and Excipient Binding on the Conformational Stabilization of a Monoclonal Antibody Suzanne J. Hudak, Associate Scientist, MedImmune, Inc. 6:00 Networking Cocktail Reception in Exhibit and Poster Hall Sponsored by Thursday, September 23, 2010 8:25 Chairperson’s Remarks Pooja Arora, Ph.D., Research Investigator II, Bristol-Myers Squibb Formulation Strategies for Vaccines 8:30 CASE STUDY Impact of Recombinant Albumin on the Stability of a Malarial Antigen Vaccine Phuong Tran, Ph.D., Senior Scientist, Research and Development, Novozymes, Australia 9:00 CASE STUDY Examining and Correlating the Long Term and Accelerated Stability of a Pneumococcal Antigen Vaccine Manvi Hasija, Ph.D., Sanofi-Pasteur, Canada 9:30 CASE STUDY Formulation and Process Considerations for Stabilization of Live Attenuated Typhoid Vaccine Satoshi Ohtake, Ph.D., Senior Scientist and Senior Manager, Aridis Pharmaceuticals 10:00 Networking Refreshment Break in Meeting Room Formulation Impacts of Device and Packaging Systems 10:30 Characterization, Modelization and Control of Primary Packaging Surfaces to Minimize Non- Native Aggregation of Therapeutic Proteins Thomas Ballet, R&D Engineer, Advanced Technology, Becton Dickinson Medical Pharmaceutical Systems 11:00 CASE STUDY Product Quality and Formulation Considerations in the Development of a Delivery System and Product Packaging Joe Fire, Senior Device and Packaging Engineer, Human Genome Sciences, Inc. 11:30 CASE STUDY The Influence of Formulation on Delivery System Design, and Vice-Versa Douglas Nesta, Ph.D., Director, Biopharmaceutical Technologies, Biopharm R&D Unit, GlaxoSmithKline 12:00 Networking Luncheon, Last Chance for Exhibit and Poster Viewing 1:25 Chairperson’s Remarks Shan Jiang, Ph.D., Director, Formulations, Seattle Genetics, Inc. Formulation Development for Next Generation Biologics 1:30 CASE STUDY Formulation Development for Antibody-Drug Conjugate (ADC) Brentuximab Vedotin (SGN-35) Shan Jiang, Ph.D., Director, Formulations, Seattle Genetics, Inc. 2:00 CASE STUDY Development and Implementation of a Thermal Melting Assay for High-Throughput Screening of Liquid Adenoviral Formulations Pieter Rijken, Ph.D., Senior Scientist, Crucell, The Netherlands 2:30 CASE STUDY Formulation Development for Subcutaneous Delivery of Plasma Derived Proteins Sylvain Huille, Ph.D., Head of Department, Biopharmaceutical Development, LFB Biotechnologies, France 3:00 Conference Ends “This IBC conference is a unique opportunity to get an overview of the latest developments in protein formulation with the technical experts from the biotech industry” – Sylvan Huille, Department Head, Formulation Development, LFB France 15 To Register, Call: (800) 390-4078 • Fax: (941) 365-0104 • E-mail: reg@ibcusa.com
Page 1 and 2: Companies that Continue to Attend Y
Page 3 and 4: Conference: September 20-24, 2010 E
Page 5 and 6: Monday, September 20, 2010 • Pre-
Page 7 and 8: Wednesday, September 22, 2010 • M
Page 9 and 10: Wednesday, September 22, 2010 (cont
Page 11 and 12: Friday, September 24, 2010 • Main
Page 13: Meet the People Behind the Products

Register Early and Save up to $300 (See page ... - IBC Life Sciences

Create successful ePaper yourself

Delete template?

Save as template?